Vous etes ici: Home


09 | 06 | 16

Liquid biopsy test - GATCLIQUID ONCOTARGET - expanded to cover blood cancers such as acute myeloid leukaemia

Worldwide unique service for highly sensitive profiling of the most relevant mutations for detection and management of  non-small cell...


11 | 05 | 16

GATC Biotech expands oncology product line with INVIEW ONCOPANEL for solid tumour profiling

Surveillance of 50 clinically relevant cancer genes  for targeted treatment of solid tumours  Treatment decision support for...


21 | 03 | 16

GATC Biotech’s liquid biopsy testing starts from as little as EUR 195 per sample

  GATC Biotech prend un positionnement tarifaire très concurrentiel pour ses   services d’analyse sur biopsies liquides :...


11 | 03 | 16

GATC Biotech Receives Reviewer’s Choice Award: Service Provider of the Year 2016

Constance, Germany, March 11, 2016: GATC Biotech AG, a world-wide leading provider of advanced genome analysis and diagnostic services, has...


15 | 02 | 16

GATC Biotech receives the TopJob Award 2016

After 2014, GATC Biotech again receives the TopJob Award for Germany's best employer among small and medium-sized enterprises with 101...



A venir




9 - 12 Juillet 2016 | Manchester, Angleterre

EACR-24 - From Basic Research to Precision Medicine




7 -11 Octobre 2016 | Copenhagen, Danemark

ESMO Congress


15 - 17 Octobre 2016 | Leipzig, Allemagne



17 - 19 Octobre 2016 | Paris, France

4th World Congress on Targeting Microbiota


Coopérer avec nous


Customized Solutions

Customized Solutions will perfectly match individual requests.

Look here for a made-to-order project design. Superb sequencing service, profound consultancy knowledge and 25 years of experience will lead you to your custom-fit approach.


Diagnostic Solutions

GATC Biotech as partner of trust within several international collaborations consolidated its expertise within Diagnostic Solutions

Expect state-of-the-art sequencing technologies, validated laboratory protocols and ISO 17025-accredited workflows. Receive reliable data, necessary know-how to succeed in the regulated market. 

Partner with us to realise the next generation of human diagnostics!



MYCOPLASMACHECK a PCR based assay to detect mycoplasma contamination in cell cultures.

Accurate - Reliable - Easy

Click here to learn more about GATC Biotech's quality control services and gain confidence in every cell culture.


The X-ray of the 21st century

Our GATCLIQUID service family offers cancer characterisation from a simple blood sample. Painful and costly tissue biopsies are replaced by non-invasive analysis of circulating tumour DNA (ctDNA). The so called liquid biopsy offers clinical researchers the opportunity to explore, screen and monitor a wide range of tumour-related mutations. This allows close surveillance of tumour dynamics and heterogeneity of a patient’s cancer.

Enter a new era of diagnostics with us!

Sequencing Solutions

Sequencing Solutions now groups our compelling Sanger sequencing services, our standardised INVIEW™ products as well as our novel modular NGSELECT.

The idea behind our Sequencing Solutions is to offer standardised one-stop solutions addressing the requirements from Sanger to NGS.



GATC Biotech introduces a novel modular system for next generation sequencing (NGS).

Build your own solution from pre-defined modules. 
Accompany us to the next level of NGS service.




20 ans de séquençage d’ADN

La société GATC Biotech est en Europe le prestataire leader de séquençage d’ADN et de bioinformatique pour l’industrie et la recherche académique.

Depuis plus de vingt ans, nous développons de nouvelles solutions globales autour du séquençage d’ADN et de l’interprétation séquentielle bioinformatique – pour des échantillons simples d’ADN et jusqu’aux projets de génome complet.

Nous comptons plus de 10.000 clients dans 40 pays du monde entier et possédons des filiales en Angleterre, en France et en Suède ; si la société GATC Biotech fait partie des leaders de cette branche.  En savoir plus

Copyright © 2016 GATC Biotech AG. All rights reserved.
RSS-Feed twitter facebook google plus linkedin xing